{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:08:40Z","timestamp":1787069320217,"version":"build-2736575974"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.jneuroim.2008.05.033","type":"journal-article","created":{"date-parts":[[2008,8,7]],"date-time":"2008-08-07T04:52:11Z","timestamp":1218084731000},"page":"221-226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["Autoantibodies in childhood opsoclonus\u2013myoclonus syndrome"],"prefix":"10.1016","volume":"201-202","author":[{"given":"F.","family":"Blaes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.G.","family":"Pike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2008.05.033_bib1","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/1097-0142(197602)37:2<846::AID-CNCR2820370233>3.0.CO;2-L","article-title":"Favorable prognosis for survival in children with coincident opso-myoclonus and neuroblastoma","volume":"37","author":"Altman","year":"1976","journal-title":"Cancer"},{"key":"10.1016\/j.jneuroim.2008.05.033_bib2","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0165-5728(00)00445-8","article-title":"Restricted IgG1 subclass of anti-Yo antibodies in paraneoplastic cerebellar degeneration","volume":"114","author":"Amyes","year":"2001","journal-title":"J. Neuroimmunol."},{"issue":"4","key":"10.1016\/j.jneuroim.2008.05.033_bib3","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/00043426-200007000-00007","article-title":"Antineuronal antibodies in patients with neuroblastoma and paraneoplastic opsoclonus\u2013myoclonus","volume":"22","author":"Antunes","year":"2000","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.jneuroim.2008.05.033_bib4","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/1531-8249(200004)47:4<504::AID-ANA14>3.0.CO;2-Q","article-title":"IgG from seronegative myasthenia gravis patients does not bind to human acetylcholine receptor expressed in HEK cells","volume":"47","author":"Blaes","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2008.05.033_bib5","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/ana.20539","article-title":"Surface-binding autoantibodies to cerebellar neurons in opsoclonus syndrome","volume":"58","author":"Blaes","year":"2005","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.jneuroim.2008.05.033_bib6","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1523\/JNEUROSCI.16-03-01114.1996","article-title":"The oncoantigen Nova-1 is a neuron-specific RNA-binding protein, the activity of which is inhibited by paraneoplastic antibodies","volume":"16","author":"Buckanovich","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2008.05.033_bib7","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/S0022-3476(97)70272-5","article-title":"Serum antibodies in childhood opsoclonus\u2013myoclonus syndrome: an analysis of antigenic targets in neural tissue","volume":"130","author":"Connolly","year":"1997","journal-title":"J. Pediatr."},{"key":"10.1016\/j.jneuroim.2008.05.033_bib8","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1750-3639.1999.tb00225.x","article-title":"Autoimmunity in paraneoplastic neurological syndromes","volume":"9","author":"Giometto","year":"1999","journal-title":"Brain Pathol."},{"key":"10.1016\/j.jneuroim.2008.05.033_bib9","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jneuroim.2005.08.018","article-title":"Functional characterisation of autoantibodies from patients with pediatric opsoclonus\u2013myoclonus\u2013syndrome","volume":"170","author":"Korfei","year":"2005","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2008.05.033_bib10","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1001\/archneur.1987.00520220043014","article-title":"Oligoclonal IgG bands in cerebrospinal fluid, principles for demonstration and interpretation based on findings in 1114 neurological patients","volume":"44","author":"Kostulas","year":"1987","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2008.05.033_bib11","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1055\/s-2007-985906","article-title":"Increased prevalence of autoimmune disorders and autoantibodies in parents of children with opsoclonus\u2013myoclonus syndrome (OMS)","volume":"38","author":"Krasenbrink","year":"2007","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.jneuroim.2008.05.033_bib12","series-title":"From Proteomics to Molecular Epidemiology: Relevance of Autoantibodies","first-page":"524","article-title":"Autoimmune disorders of the neuromuscular junction","author":"Lang","year":"2002"},{"key":"10.1016\/j.jneuroim.2008.05.033_bib13","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/ana.410290303","article-title":"Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer","volume":"29","author":"Luque","year":"1991","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2008.05.033_bib14","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1200\/JCO.2000.18.16.3012","article-title":"Natural course of neuroblastoma detected by mass screening: a 5-year prospective study at a single institution","volume":"18","author":"Nishihara","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jneuroim.2008.05.033_bib15","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1056\/NEJM199501193320317","article-title":"Improvement of paraneoplastic opsoclonus\u2013myoclonus after protein A column therapy","volume":"332","author":"Nitschke","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2008.05.033_bib16","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/BF01953945","article-title":"Neurological sequelae of the dancing eye syndrome","volume":"155","author":"Pohl","year":"1966","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.jneuroim.2008.05.033_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00002826-199619010-00001","article-title":"The immunopharmacology of the opsoclonus\u2013myoclonus syndrome","volume":"19","author":"Pranzatelli","year":"1996","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.jneuroim.2008.05.033_bib18","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/(SICI)1096-911X(199704)28:4<284::AID-MPO7>3.0.CO;2-E","article-title":"Long-term neurologic outcome in children with opsoclonus\u2013myoclonus associated with neuroblastoma. A report from the Pediatric Oncology Group","volume":"2","author":"Russo","year":"1997","journal-title":"Med. Pediatr. Oncol."},{"key":"10.1016\/j.jneuroim.2008.05.033_bib19","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1212\/WNL.45.10.1873","article-title":"Immunisation with the paraneoplastic encephalomyelitis antigen HuD does not cause neurological disease in mice","volume":"45","author":"Sillevis Smitt","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2008.05.033_bib20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/(SICI)1096-911X(199801)30:1<15::AID-MPO6>3.0.CO;2-3","article-title":"Effect of steroid and high-dose immunoglobulin therapy on opsoclonus\u2013myoclonus syndrome occurring in neuroblastoma","volume":"30","author":"Veneselli","year":"1998","journal-title":"Med. Pediatr. Oncol."},{"key":"10.1016\/j.jneuroim.2008.05.033_bib21","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0165-5728(97)00124-0","article-title":"Paraneoplastic anti-Hu serum: studies on human tumour cell lines","volume":"79","author":"Verschurren","year":"1997","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2008.05.033_bib22","first-page":"1","article-title":"Measuring and evaluating the significance of autoantibodies in neurological disorders","volume":"2","author":"Vincent","year":"2002","journal-title":"Clin. Appl. Immunol. Rev."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016557280800221X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016557280800221X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:11:43Z","timestamp":1759047103000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016557280800221X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":22,"alternative-id":["S016557280800221X"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2008.05.033","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoantibodies in childhood opsoclonus\u2013myoclonus syndrome","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2008.05.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}